Geoffrey Wool to Anticoagulants
This is a "connection" page, showing publications Geoffrey Wool has written about Anticoagulants.
Connection Strength
1.447
-
Benefits and Pitfalls of Point-of-Care Coagulation Testing for Anticoagulation Management: An ACLPS Critical Review. Am J Clin Pathol. 2019 01 01; 151(1):1-17.
Score: 0.533
-
Pathology consultation on anticoagulation monitoring: factor X-related assays. Am J Clin Pathol. 2013 Nov; 140(5):623-34.
Score: 0.373
-
Confirming Point-of-Care INR Test Results-Reply. JAMA. 2020 03 24; 323(12):1191-1192.
Score: 0.145
-
The Point-of-Care INR Test for Vitamin K Antagonist Monitoring. JAMA. 2019 12 03; 322(21):2129-2130.
Score: 0.142
-
The management of anticoagulation in patients undergoing therapeutic plasma exchange: A concise review. J Clin Apher. 2018 Jun; 33(3):371-379.
Score: 0.123
-
Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic? Blood Adv. 2023 08 08; 7(15):4112-4123.
Score: 0.046
-
Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies. Blood. 2022 12 22; 140(25):2722-2729.
Score: 0.044
-
Interlaboratory Performance in Measurement of Dabigatran and Rivaroxaban. Arch Pathol Lab Med. 2022 01 02; 146(2):145-153.
Score: 0.041